argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
11 dec 2022 - 21:07
Statutory name
argenx SE
Title
argenx to Present Pivotal ADVANCE Trial Data During ASH Plenary Session Highlighting VYVGART® (efgartigimod alfa-fcab) as Potential New Treatment Modality for Immune Thrombocytopenia